Martin W. Mackay
2022
In 2022, Martin W. Mackay earned a total compensation of $1.4M as Chief Executive Officer and Chairman at Rallybio Corp, a 52% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $198,916 |
---|---|
Option Awards | $691,108 |
Salary | $491,150 |
Other | $17,000 |
Total | $1,398,174 |
Mackay received $691.1K in option awards, accounting for 49% of the total pay in 2022.
Mackay also received $198.9K in non-equity incentive plan, $491.2K in salary and $17K in other compensation.
Rankings
In 2022, Martin W. Mackay's compensation ranked 2,378th out of 5,760 executives tracked by ExecPay. In other words, Mackay earned more than 58.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,378 out of 5,760 | 59th |
Division Manufacturing | 1,304 out of 3,136 | 58th |
Major group Chemicals And Allied Products | 580 out of 1,422 | 59th |
Industry group Drugs | 535 out of 1,323 | 60th |
Industry Pharmaceutical Preparations | 386 out of 969 | 60th |
Source: SEC filing on April 10, 2023.
Mackay's colleagues
We found two more compensation records of executives who worked with Martin W. Mackay at Rallybio Corp in 2022.